Fluorescent A 2A and A 3 adenosine receptor antagonists as flow cytometry probes

Adenosine receptor (AR) ligands are being developed for metabolic, cardiovascular, neurological, and inflammatory diseases and cancer. The ease of drug discovery is contingent on the availability of pharmacological tools. Fluorescent antagonist ligands for the human A and A ARs were synthesized usin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Purinergic signalling 2023-09, Vol.19 (3), p.565
Hauptverfasser:	Toti, Kiran S, Campbell, Ryan G, Lee, Hobin, Salmaso, Veronica, Suresh, R Rama, Gao, Zhan-Guo, Jacobson, Kenneth A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine A2 Receptor Antagonists - pharmacology Amines Flow Cytometry Fluorescent Dyes HEK293 Cells Humans Purinergic P1 Receptor Antagonists - pharmacology Receptor, Adenosine A2A - metabolism Receptor, Adenosine A3 - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!